Effects of bee venom against Propionibacterium acnes‑induced inflammation in human keratinocytes and monocytes

Kim,Jung-Yeon; Lee,Woo-Ram; Kim,Kyung-Hyun; An,Hyun-Jin; Chang,Young-Chae; Han,Sang-Mi; Park,Yoon-Yub; Pak,Sok Cheon; Park,Kwan-Kyu

doi:10.3892/ijmm.2015.2180

Effects of bee venom against Propionibacterium acnes‑induced inflammation in human keratinocytes and monocytes

Authors:
- Jung-Yeon Kim
- Woo-Ram Lee
- Kyung-Hyun Kim
- Hyun-Jin An
- Young-Chae Chang
- Sang-Mi Han
- Yoon-Yub Park
- Sok Cheon Pak
- Kwan-Kyu Park
View Affiliations

Affiliations: Department of Pathology, School of Medicine, Catholic University of Daegu, Daegu 705‑178, Republic of Korea, Department of Agricultural Biology, National Institute of Agricultural Science and Technology, Wanju 565‑851, Republic of Korea, Department of Physiology, School of Medicine, Catholic University of Daegu, Daegu 705‑178, Republic of Korea , School of Biomedical Sciences, Charles Sturt University, Bathurst NSW 2795, Australia
Published online on: April 9, 2015 https://doi.org/10.3892/ijmm.2015.2180
Pages: 1651-1656

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Propionibacterium acnes (P. acnes) cause inflammatory acne and play an important role in the pathogenesis of acne by inducing inflammatory mediators. P. acnes contributes to the inflammatory responses of acne by activating inflammatory cells, keratinocytes and sebocytes to secrete pro‑inflammatory cytokines such as tumor necrosis factor‑α (TNF‑α), interleukin (IL)‑1β and IL‑8. Bee venom has traditionally been used in the treatment of certain immune‑related diseases. However, there has not yet been a robust trial to prove the therapeutic effect of bee venom in skin inflammation. The aim of the present study was to investigate anti‑inflammatory properties of bee venom in skin inflammation induced by P. acnes using keratinocytes (HaCaT) and monocytes (THP‑1). P. acnes is known to stimulate the production of pro‑inflammatory cytokines such as IL‑1, IL‑8, IL‑12 and TNF‑α. In the present study, the production of interferon‑γ (IFN‑γ), IL‑1β, IL‑8 and TNF‑α was increased by P. acnes treatment in HaCaT and THP‑1 cells. By contrast, bee venom effectively inhibited the secretion of IFN‑γ, IL‑1β, IL‑8 and TNF‑α. Furthermore, P. acnes treatment activated the expression of IL‑8 and toll‑like receptor 2 (TLR2) in HaCaT cells. However, bee venom inhibited the expression of IL‑8 and TLR2 in heat‑killed P. acnes. Based on these results, it is concluded that bee venom has an effective anti‑inflammatory activity against P. acnes in HaCaT and THP‑1 cells. Therefore, we suggest that bee venom is an alternative treatment to antibiotic therapy of acne.

View Figures

View References

1	Leyden JJ: The evolving role of Propionibacterium acnes in acne. Semin Cutan Med Surg. 20:139–143. 2001. View Article : Google Scholar : PubMed/NCBI
2	Jappe U: Pathological mechanisms of acne with special emphasis on Propionibacterium acnes and related therapy. Acta Derm Venereol. 83:241–248. 2003. View Article : Google Scholar : PubMed/NCBI
3	Toyoda M and Morohashi M: Pathogenesis of acne. Med Electron Microsc. 34:29–40. 2001. View Article : Google Scholar : PubMed/NCBI
4	Leyden JJ, McGinley KJ, Mills OH and Kligman AM: Propionibacterium levels in patients with and without acne vulgaris. J Invest Dermatol. 65:382–384. 1975. View Article : Google Scholar : PubMed/NCBI
5	Vowels BR, Yang S and Leyden JJ: Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne. Infect Immun. 63:3158–3165. 1995.PubMed/NCBI
6	Raingeaud J and Pierre J: Interleukin-4 downregulates TNFalpha-induced IL-8 production in keratinocytes. FEBS Lett. 579:3953–3959. 2005. View Article : Google Scholar : PubMed/NCBI
7	Feliciani C, Gupta AK and Sauder DN: Keratinocytes and cytokine/growth factors. Crit Rev Oral Biol Med. 7:300–318. 1996. View Article : Google Scholar : PubMed/NCBI
8	Baggiolini M: Chemokines and leukocyte traffic. Nature. 392:565–568. 1998. View Article : Google Scholar : PubMed/NCBI
9	Ochsendorf F: Systemic antibiotic therapy of acne vulgaris. J Dtsch Dermatol Ges. 4:828–841. 2006.In German. View Article : Google Scholar : PubMed/NCBI
10	Eady EA: Bacterial resistance in acne. Dermatology. 196:59–66. 1998. View Article : Google Scholar : PubMed/NCBI
11	Eady EA, Cove JH, Holland KT and Cunliffe WJ: Erythromycin resistant propionibacteria in antibiotic treated acne patients: Association with therapeutic failure. Br J Dermatol. 121:51–57. 1989. View Article : Google Scholar : PubMed/NCBI
12	Nam C, Kim S, Sim Y and Chang I: Anti-acne effects of Oriental herb extracts: A novel screening method to select anti-acne agents. Skin Pharmacol Appl Skin Physiol. 16:84–90. 2003. View Article : Google Scholar : PubMed/NCBI
13	Tan HH: Antibacterial therapy for acne: A guide to selection and use of systemic agents. Am J Clin Dermatol. 4:307–314. 2003. View Article : Google Scholar : PubMed/NCBI
14	Hider RC: Honeybee venom: A rich source of pharmacologically active peptides. Endeavour. 12:60–65. 1988. View Article : Google Scholar : PubMed/NCBI
15	Habermann E: Bee and wasp venoms. Science. 177:314–322. 1972. View Article : Google Scholar : PubMed/NCBI
16	Kwon YB, Lee HJ, Han HJ, et al: The water-soluble fraction of bee venom produces antinociceptive and anti-inflammatory effects on rheumatoid arthritis in rats. Life Sci. 71:191–204. 2002. View Article : Google Scholar : PubMed/NCBI
17	Kwon YB, Lee JD, Lee HJ, et al: Bee venom injection into an acupuncture point reduces arthritis associated edema and nociceptive responses. Pain. 90:271–280. 2001. View Article : Google Scholar : PubMed/NCBI
18	Stieger M, Wuthrich B, Wyss S and Kopper E: Clinical picture and diagnosis of bee-venom allergy. A comparison between skin tests and RAST determinations. Hautarzt. 29:632–637. 1978.In German. PubMed/NCBI
19	Ip SW, Liao SS, Lin SY, et al: The role of mitochondria in bee venom-induced apoptosis in human breast cancer MCF7 cells. In Vivo. 22:237–245. 2008.PubMed/NCBI
20	Orsolic N: Bee venom in cancer therapy. Cancer Metastasis Rev. 31:173–194. 2012. View Article : Google Scholar
21	Park MH, Choi MS, Kwak DH, et al: Anti-cancer effect of bee venom in prostate cancer cells through activation of caspase pathway via inactivation of NF-kappaB. Prostate. 71:801–812. 2011. View Article : Google Scholar : PubMed/NCBI
22	Dombrowski Y, Peric M, Koglin S, et al: Honey bee (Apis mellifera) venom induces AIM2 inflammasome activation in human keratinocytes. Allergy. 67:1400–1407. 2012. View Article : Google Scholar : PubMed/NCBI
23	Han SM, Lee GG and Park KK: Acute dermal toxicity study of bee venom (Apis mellifera L.) in rats. Toxicol Res. 28:99–102. 2012. View Article : Google Scholar : PubMed/NCBI
24	Guin JD, Huber DS and Gielerak PL: Antibiotic sensitivity of comedonal Propionibacterium acnes. Acta Derm Venereol. 59:552–554. 1979.PubMed/NCBI
25	Webster GF and Graber EM: Antibiotic treatment for acne vulgaris. Semin Cutan Med Surg. 27:183–187. 2008. View Article : Google Scholar : PubMed/NCBI
26	Humphrey S: Antibiotic resistance in acne treatment. Skin Therapy Lett. 17:1–3. 2012.PubMed/NCBI
27	Park HJ, Lee SH, Son DJ, et al: Antiarthritic effect of bee venom: Inhibition of inflammation mediator generation by suppression of NF-kappaB through interaction with the p50 subunit. Arthritis Rheum. 50:3504–3515. 2004. View Article : Google Scholar : PubMed/NCBI
28	Lee WR, Kim SJ, Park JH, et al: Bee venom reduces athero-sclerotic lesion formation via anti-inflammatory mechanism. Am J Chin Med. 38:1077–1092. 2010. View Article : Google Scholar
29	Jugeau S, Tenaud I, Knol AC, et al: Induction of toll-like receptors by Propionibacterium acnes. Br J Dermatol. 153:1105–1113. 2005. View Article : Google Scholar : PubMed/NCBI
30	Kim J, Ochoa MT, Krutzik SR, et al: Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol. 169:1535–1541. 2002. View Article : Google Scholar : PubMed/NCBI
31	Koreck A, Pivarcsi A, Dobozy A and Kemeny L: The role of innate immunity in the pathogenesis of acne. Dermatology. 206:96–105. 2003. View Article : Google Scholar : PubMed/NCBI
32	Kim J: Review of the innate immune response in acne vulgaris: Activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses. Dermatology. 211:193–198. 2005. View Article : Google Scholar : PubMed/NCBI
33	Hari A, Flach TL, Shi Y and Mydlarski PR: Toll-like receptors: Role in dermatological disease. Mediators Inflamm. 2010:4372462010. View Article : Google Scholar : PubMed/NCBI
34	Pivarcsi A, Bodai L, Rethi B, et al: Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. Int Immunol. 15:721–730. 2003. View Article : Google Scholar : PubMed/NCBI
35	Kollisch G, Kalali BN, Voelcker V, et al: Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes. Immunology. 114:531–541. 2005. View Article : Google Scholar : PubMed/NCBI
36	Schmidt N and Gans EH: Tretinoin: A review of its anti-inflammatory properties in the treatment of acne. J Clin Aesthet Dermatol. 4:22–29. 2011.PubMed/NCBI
37	Kock A, Schwarz T, Kirnbauer R, et al: Human keratinocytes are a source for tumor necrosis factor alpha: Evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med. 172:1609–1614. 1990. View Article : Google Scholar : PubMed/NCBI
38	Beljaards RC, Van Beek P, Nieboer C, Stoof TJ and Boorsma DM: The expression of interleukin-8 receptor in untreated and treated psoriasis. Arch Dermatol Res. 289:440–443. 1997. View Article : Google Scholar : PubMed/NCBI
39	Nagy I, Pivarcsi A, Koreck A, Szell M, Urban E and Kemeny L: Distinct strains of Propionibacterium acnes induce selective human beta-defensin-2 and interleukin-8 expression in human keratinocytes through toll-like receptors. J Invest Dermatol. 124:931–938. 2005. View Article : Google Scholar : PubMed/NCBI